Literature DB >> 3029803

Experimental and human brain neoplasms: detection with in vivo sodium MR imaging.

P A Turski, L W Houston, W H Perman, J K Hald, D Turski, C M Strother, J F Sackett.   

Abstract

Elevations of intracellular sodium concentration have been observed in rapidly proliferating cells and malignant neoplasms. Sodium magnetic resonance (MR) imaging (with repetition times of 133 msec and echo times of 13, 26, 39, and 42 msec) was performed in ten patients and three dogs with central nervous system neoplasms. In all instances the neoplasms were associated with an increased sodium signal compared with that of normal brain. Unfortunately, the available echo times did not enable discrimination of intracellular sodium from extracellular sodium, which was present in high concentrations in adjacent vasogenic edema fluid. Further study is necessary to establish the utility of sodium MR imaging for the investigation of malignant neoplasms.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3029803     DOI: 10.1148/radiology.163.1.3029803

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  13 in total

1.  Sodium MR imaging detection of mild Alzheimer disease: preliminary study.

Authors:  E A Mellon; D T Pilkinton; C M Clark; M A Elliott; W R Witschey; A Borthakur; R Reddy
Journal:  AJNR Am J Neuroradiol       Date:  2009-02-12       Impact factor: 3.825

2.  Noninvasive electrical conductivity measurement by MRI: a test of its validity and the electrical conductivity characteristics of glioma.

Authors:  Khin Khin Tha; Ulrich Katscher; Shigeru Yamaguchi; Christian Stehning; Shunsuke Terasaka; Noriyuki Fujima; Kohsuke Kudo; Ken Kazumata; Toru Yamamoto; Marc Van Cauteren; Hiroki Shirato
Journal:  Eur Radiol       Date:  2017-07-11       Impact factor: 5.315

Review 3.  Neuroimaging of Peptide-based Vaccine Therapy in Pediatric Brain Tumors: Initial Experience.

Authors:  Andre D Furtado; Rafael Ceschin; Stefan Blüml; Gary Mason; Regina I Jakacki; Hideho Okada; Ian F Pollack; Ashok Panigrahy
Journal:  Neuroimaging Clin N Am       Date:  2017-02       Impact factor: 2.264

4.  Residual Tumor Volume, Cell Volume Fraction, and Tumor Cell Kill During Fractionated Chemoradiation Therapy of Human Glioblastoma using Quantitative Sodium MR Imaging.

Authors:  Keith R Thulborn; Aiming Lu; Ian C Atkinson; Mohan Pauliah; Kathryn Beal; Timothy A Chan; Antonio Omuro; Josh Yamada; Michelle S Bradbury
Journal:  Clin Cancer Res       Date:  2018-11-28       Impact factor: 12.531

5.  Low-grade glioma: correlation of short echo time 1H-MR spectroscopy with 23Na MR imaging.

Authors:  R Bartha; J F Megyesi; C J Watling
Journal:  AJNR Am J Neuroradiol       Date:  2008-01-31       Impact factor: 3.825

6.  Magnetic resonance imaging and histopathology of cerebral gliomas.

Authors:  M Watanabe; R Tanaka; N Takeda
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

7.  Sodium-MR-imaging of the brain: initial clinical results.

Authors:  W Grodd; U Klose
Journal:  Neuroradiology       Date:  1988       Impact factor: 2.804

8.  Quantitative sodium imaging and gliomas: a feasibility study.

Authors:  Lucidio P Nunes Neto; Guillaume Madelin; Terlika Pandit Sood; Chih-Chun Wu; Douglas Kondziolka; Dimitris Placantonakis; John G Golfinos; Andrew Chi; Rajan Jain
Journal:  Neuroradiology       Date:  2018-06-03       Impact factor: 2.804

Review 9.  Sodium homeostasis in the tumour microenvironment.

Authors:  Theresa K Leslie; Andrew D James; Fulvio Zaccagna; James T Grist; Surrin Deen; Aneurin Kennerley; Frank Riemer; Joshua D Kaggie; Ferdia A Gallagher; Fiona J Gilbert; William J Brackenbury
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-07-23       Impact factor: 10.680

10.  Rapid in vivo Taxotere quantitative chemosensitivity response by 4.23 Tesla sodium MRI and histo-immunostaining features in N-Methyl-N-Nitrosourea induced breast tumors in rats.

Authors:  Rakesh Sharma; Richard P Kline; Ed X Wu; Jose K Katz
Journal:  Cancer Cell Int       Date:  2005-08-03       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.